Showing results (1121-1130 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|April 1, 1992
Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplantsP R Henon, H Liang, G Beck-Wirth, et al.
Bone Marrow Transplantation|August 28, 2003
Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantationB A Lynch, M A Vasef, M Comito, et al.
Bone Marrow Transplantation|August 28, 2003
Syngeneic graft-versus-host disease: a report of two cases and literature reviewT Latif, B Pohlman, M Kalaycio, et al.
Bone Marrow Transplantation|September 4, 2003
A randomised study of 10 microg/kg/day (single dose) vs 2 x 5 microg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patientsR Carrión, D Serrano, A Gómez-Pineda, et al.
Bone Marrow Transplantation|September 4, 2003
Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?E Jantunen, T Kuittinen, T Nousiainen
Bone Marrow Transplantation|September 4, 2003
Progenitor content of autologous grafts: mobilized bone marrow vs mobilized bloodE Dahl, J Burroughs, T DeFor, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Bone Marrow Transplantation|September 4, 2003
Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approachJ-M Tiercy, S Stadelmann, B Chapuis, et al.
Bone Marrow Transplantation|September 4, 2003
Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuriaM Ditschkowski, R Trenschel, G Kummer, et al.
Bone Marrow Transplantation|January 1, 1992
Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumorsD Kotasek, K M Shepherd, R E Sage, et al.
Pageof 993